EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Microglial Inhibition Promotes Proliferation and Differentiation of Neural Stem Cells via STAT3 / SDF ‐1/ CXCR4 Signaling Pathway in Hypoxic–Ischemic Encephalopathy

Ao Ding, Guiqin Duan, Mingwei Zhu, Li Chen, Jie Luo iD, Ting Tan, Zilin Li, Wenhui Wang, Jun Wang, Yuan Chen, Ya-Ping Tang

Glia · 2026-05 · 74 (5)

DOI: 10.1002/glia.70149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Glia, online erschienen am 26.03.2026. Verfasst von Ao Ding und 10 weiteren Autor:innen. Beteiligte Einrichtung: Neurobiology Research Center, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, China. Hauptthemen laut MEDLINE: Microglia, Hypoxia-Ischemia, Brain, Neural Stem Cells, Cell Proliferation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangzhou Health Care Cooperative Innovation Major Project, the Natural Science Foundation of Guangdong Province, the National Natural Science Foundation of China (NSFc).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neonatal hypoxic–ischemic encephalopathy (HIE) may induce substantial neuronal damage. In particular, an overactivation of microglia following HIE represents a pathogenically important process. Previous studies have shown that microglial inhibitors can exert neuroprotective effects in HIE; however, the specific mechanisms underlying these effects have not yet been elucidated. Ligation of the left common carotid artery and exposure to 5% O 2 were utilized to produce an HIE model in rats. A number of experimental approaches were then used to determine the effect of a microglial inhibition, achieved via the administration of GW2580, a Csf1r inhibitor, and investigate the mechanisms involved. Our HIE models exhibited substantial brain infarction and were significantly impaired in motor functions ( p < 0.01–0.001, in all tests examined). In the infarction areas, the number of microglia, macrophages, and neural stem cells (NSCs) was all dramatically increased over that in sham‐injured rats, respectively ( p < 0.05–0.001). The administration of GW2580 significantly reduced the numbers of microglia and macrophages, but increased the number of NSCs when compared to those in vehicle‐treated HIE models ( p < 0.05–0.001). Furthermore, GW2580 significantly ameliorated both the histological and behavioral phenotypes in HIE rats and increased STAT phosphorylation ( p < 0.05–0.001). Finally, the inhibition or activation of STAT3 respectively decreased or increased the neuroprotective effects of GW2580 ( p < 0.05–0.001). Collectively, our findings demonstrate that the STAT3 signaling pathway plays a critical role in the neuroprotective effects of microglial inhibition and may facilitate the development of novel therapeutic strategies to treat stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaHypoxia-Ischemia, BrainNeural Stem CellsCell ProliferationCell DifferentiationAnimalsSTAT3 Transcription FactorSignal TransductionRats, Sprague-DawleyReceptors, CXCR4Animals, NewbornDisease Models, AnimalRatsPyrimidinesMaleAnisoles

Stichwörter der Autor:innen

GW2580STAT3 signaling pathwayhypoxic–ischemic encephalopathymicrogliamicroglial inhibitionneural stem cells

Substanzen

STAT3 Transcription FactorReceptors, CXCR4Stat3 protein, rat5-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamineCxcr4 protein, ratPyrimidinesAnisoles

Autor:innen und Institutionen

  • Neurobiology Research Center, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, China.
  • Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
  • Institute of Neurological Disease, West China School of Medicine, Sichuan University, Sichuan University Affiliated Chengdu Second People's Hospital, Chengdu, China.
  • Department of Child Health, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

ORCID-Profile: Jie Luo

Förderung

  • Guangzhou Health Care Cooperative Innovation Major Project
  • the Natural Science Foundation of Guangdong Province
  • the National Natural Science Foundation of China (NSFc)
  • Key Scientific and Technological Project of Guangzhou City
  • Key Scientific and Technological Project of Guangdong Province
  • Key Technologies R&D Program of Sichuan Province of China
  • Natural Science Foundation of Guangdong Province
  • National Natural Science Foundation of China

Zitieren

APA

Ding, A., Duan, G., Zhu, M., Chen, L., Luo, J., Tan, T., Li, Z., Wang, W., Wang, J., Chen, Y., & Tang, Y. P. (2026). Microglial Inhibition Promotes Proliferation and Differentiation of Neural Stem Cells via STAT3 / SDF ‐1/ CXCR4 Signaling Pathway in Hypoxic–Ischemic Encephalopathy. Glia, 74(5). https://doi.org/10.1002/glia.70149

Vancouver

Ding A, Duan G, Zhu M, Chen L, Luo J, Tan T, et al. Microglial Inhibition Promotes Proliferation and Differentiation of Neural Stem Cells via STAT3 / SDF ‐1/ CXCR4 Signaling Pathway in Hypoxic–Ischemic Encephalopathy. Glia. 2026;74(5). doi:10.1002/glia.70149

BibTeX
@article{Ding2026,
  author = {Ding, Ao and Duan, Guiqin and Zhu, Mingwei and Chen, Li and Luo, Jie and Tan, Ting and Li, Zilin and Wang, Wenhui and Wang, Jun and Chen, Yuan and Tang, Ya-Ping},
  title = {Microglial Inhibition Promotes Proliferation and Differentiation of Neural Stem Cells via STAT3 / SDF ‐1/ CXCR4 Signaling Pathway in Hypoxic–Ischemic Encephalopathy},
  journal = {Glia},
  year = {2026},
  volume = {74},
  number = {5},
  doi = {10.1002/glia.70149}
}
Kostenlos starten →